Articles from Adverse Event Reporting News (December 17, 2007)

Title	Author	Type	Words
ADHD drugs may boost ER visits.		Brief article	269
AHRQ study compares efficacy, risks of osteoporosis drugs.			443
Committee opposes use of Avastin for breast cancer.			527
Conferences.		Calendar	283
Contraindications and warnings August--2007.			6978
Dental devices can cause serious burns, FDA warns.		Brief article	190
Exjade label to warn of hepatic failure.		Brief article	271
FDA committee rejects making Mevacor OTC.			622
FDA eases access to Accutane.		Brief article	233
FDA expects to toughen coated-stent guidelines.		Brief article	268
FDA finds no evidence of increased cardiac events with Nexium or Prilosec.			408
FDA issues alert for DDAVP nasal spray, usage could cause seizures.		Brief article	139
FDA issues alert on radio frequency ablation devices due to patient deaths.		Brief article	143
FDA strengthens warnings on certain epilepsy drugs.			369
Lawmakers seek probe into FDA vote on Provenge.			525
Mayo clinic study links anemia drugs to leukemia risk.			486
OHRP still grappling with how to report AEs to IRBs, despite guidance.	Cezanne, Jeannette	Report	849
Two U.S. health care providers drop Avandia.		Brief article	151
USP, Quantros form alliance to enhance MEDMARX system.		Brief article	188